Literature DB >> 20066302

Directed evolution of gold nanoparticle delivery to cells.

Na Li1, Timothy Larson, Hong H Nguyen, Konstantin V Sokolov, Andrew D Ellington.   

Abstract

A newly selected anti-receptor (anti-EGFR) aptamer was conjugated to gold nanoparticles via a facile hybridization method and was found to specifically and quantitatively direct the delivery of gold nanoparticles to cells expressing EGFR through receptor-mediated endocytosis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20066302      PMCID： PMC3826538          DOI： 10.1039/b920865h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  24 in total

1.  Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles.

Authors:  Konstantin Sokolov; Michele Follen; Jesse Aaron; Ina Pavlova; Anais Malpica; Reuben Lotan; Rebecca Richards-Kortum
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

Review 2.  Nanoparticles for bioimaging.

Authors:  Parvesh Sharma; Scott Brown; Glenn Walter; Swadeshmukul Santra; Brij Moudgil
Journal:  Adv Colloid Interface Sci       Date:  2006-08-04       Impact factor: 12.984

3.  Properties of the receptor for epidermal growth factor.

Authors:  G Carpenter
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

4.  Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes.

Authors:  C R Miller; B Bondurant; S D McLean; K A McGovern; D F O'Brien
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

5.  Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.

Authors:  Devika R Bhumkar; Hrushikesh M Joshi; Murali Sastry; Varsha B Pokharkar
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.200

6.  Oligonucleotide-modified gold nanoparticles for intracellular gene regulation.

Authors:  Nathaniel L Rosi; David A Giljohann; C Shad Thaxton; Abigail K R Lytton-Jean; Min Su Han; Chad A Mirkin
Journal:  Science       Date:  2006-05-19       Impact factor: 47.728

7.  Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.

Authors:  X Wen; Q P Wu; S Ke; L Ellis; C Charnsangavej; A S Delpassand; S Wallace; C Li
Journal:  J Nucl Med       Date:  2001-10       Impact factor: 10.057

Review 8.  Autocrine, paracrine and juxtacrine signaling by EGFR ligands.

Authors:  Amar B Singh; Raymond C Harris
Journal:  Cell Signal       Date:  2005-10       Impact factor: 4.315

9.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance.

Authors:  L R Hirsch; R J Stafford; J A Bankson; S R Sershen; B Rivera; R E Price; J D Hazle; N J Halas; J L West
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 10.  The biochemistry and physiology of the receptor-kinase for epidermal growth factor.

Authors:  G Carpenter
Journal:  Mol Cell Endocrinol       Date:  1983-07       Impact factor: 4.102
View more
  39 in total

1.  Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures.

Authors:  Günter Mayer; Marie-Sophie L Ahmed; Andreas Dolf; Elmar Endl; Percy A Knolle; Michael Famulok
Journal:  Nat Protoc       Date:  2010-12-02       Impact factor: 13.491

Review 2.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

Review 3.  Tracking RNA with light: selection, structure, and design of fluorescence turn-on RNA aptamers.

Authors:  Robert J Trachman; Adrian R Ferré-D'Amaré
Journal:  Q Rev Biophys       Date:  2019-08-19       Impact factor: 5.318

Review 4.  Molecular aptamers for drug delivery.

Authors:  Weihong Tan; Hui Wang; Yan Chen; Xiaobing Zhang; Haizhen Zhu; Chaoyong Yang; Ronghua Yang; Chen Liu
Journal:  Trends Biotechnol       Date:  2011-08-06       Impact factor: 19.536

5.  RNA aptamers and their therapeutic and diagnostic applications.

Authors:  Katherine Germer; Marissa Leonard; Xiaoting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2013-03-31

Review 6.  Aptamers as Therapeutics.

Authors:  Shahid M Nimjee; Rebekah R White; Richard C Becker; Bruce A Sullenger
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-01-06       Impact factor: 13.820

7.  Stabilized Interleukin-6 receptor binding RNA aptamers.

Authors:  Cindy Meyer; Katharina Berg; Katja Eydeler-Haeder; Inken Lorenzen; Joachim Grötzinger; Stefan Rose-John; Ulrich Hahn
Journal:  RNA Biol       Date:  2013-12-20       Impact factor: 4.652

8.  Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells.

Authors:  Partha Ray; Marcus A Cheek; Mariam L Sharaf; Na Li; Andrew D Ellington; Bruce A Sullenger; Barbara Ramsay Shaw; Rebekah R White
Journal:  Nucleic Acid Ther       Date:  2012-10       Impact factor: 5.486

Review 9.  EGF receptor-targeted nanocarriers for enhanced cancer treatment.

Authors:  Alyssa M Master; Anirban Sen Gupta
Journal:  Nanomedicine (Lond)       Date:  2012-12       Impact factor: 5.307

10.  Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield.

Authors:  Timothy A Larson; Pratixa P Joshi; Konstantin Sokolov
Journal:  ACS Nano       Date:  2012-09-25       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.